快好知 kuaihz


hepatoma造句
1. Monolayers of human hepatoma cell line Hep3B were maintained in Dulbecco modified Eagle's medium supplemented with 10% fetal calf serum. 2. Hepatoma cells in culture secrete PLA2 into the culture medium when stimulated by interleukin 6. 3. Hepatoma cells are differentiated tumor cells derived from liver. 4. The therapeutic effectiveness of 10 cases of malignant hepatoma in children were evaluated with traditional typing and staging histologic subtyping and TNM staging. 5. Conclusions AT can obviously inhibit the growth of hepatoma cell through inducing hepatoma cell apoptosis. 6. Partial hepatectomy was performed in 11 patients with hepatoma pretreated by dextran hepatic artery embolization. 7. Methods Growth of mouse ascites hepatoma 22 (H 22) cells and splenocyte proliferation were investigated in vitro by MTT colorimetric assay. 8. Conclusion Epigastric metastasis of primary hepatoma, cholecystic carcinoma, pancreatic carcinoma and gastric carcinoma have different features, although there are some of the same CT signs. 9. This hepatoma cell strain will be a useful model in thechemotherapy drug resistant research of hepatoma. 10. Conclusion Indwelling hepatoma after MTC treatment could activize the anti tumor immunity of the patients. 11. Objective: To observe the inhibitory effects of biotic royal jelly on the ascitic hepatoma cell H22. 12. Objective: To investigate the co-inhibition effect of trichosanthin (TCS) and arsenacetylic acid( ASAC )on hepatoma cells of SMMC-7721. 13. The second part of this experiment is the study of the apoptotic effects of sarsasapogenin on human hepatoma HepG2 cells. 14. Objective : To screen for the gene clones with differential expression in normal liver and hepatoma. 15. Objective To explore the effects of heparan sulphate in combination with constant magnetic fields on the proliferation and apoptosis of the human hepatoma cell line (HepG2). 16. Conclusion: Complex Prescription Inj. of Kuhseng(Inj. Yan-shu) combined with Complex Prescription Capsule of Cantharides has good and reliable effect on hepatoma in advanced stage. 17. Conclusion: Subtractive immunization techniques could be used to analyze the transiently expressed antigens of hepatoma apoptotic cells. 18. Objective: To investigate the anti-proliferative effect of compounds isolated from Black Nightshade Herb in vitro on human hepatoma cell line FHCC-98. 19. In normal individual, conversion of proinsulin to insulin is mediated by two endoproteases, PC2 and PC3. There are no PC2 and PC3 but furin in hepatoma cells. 20. Abnormal protherombin obvious increased can act as screeing diagnosis for primary hepatoma. 21. CONCLUSION Polysaccharide from fermented Tremella fuciformis have better inhibition effects on U14 cervical cancer, H22 hepatoma and S180 sarcoma in mice. 22. Primary tumors are and include benign hepatocellular adenoma ( hepatoma ) and malignant hepatic carcinoids. 23. Conclusion Although the same CT signs, upper abdominal metastasis of Primary Hepatoma, cholecystic carcinoma, pancreatic carcinoma and gastric carcinoma has different feature. 24. Aim: To explore the role of subtractive immunization techniques in analysis of some transiently expressed antigens of hepatoma apoptotic cells during apoptotic response. 25. Method The alteration of serum LSA concentration and serum ADA activity were investigated in Sprague-Dawley (SD) rats inducing with 2- Fluorenyl -acetamide during the development of rat hepatoma. 26. Objective : To observe immune anti - tumor effect of Shiquandabu decoction and Jinlingzi powder in hepatoma - xenograft rats. 27. Results Inhibition of carcinoma cells from hydrogaster induced by carboplatin, cisplatin and adriamycin obviously stronger than leukocyte in many hepatoma(P0.05). 28. The alpha-fetoprotein(AFP) gene, a member of the albuminoid gene family, plays an important role in individual development. It is also a sign of hepatoma when its concentration is high in the adult. 29. Objective To explore the postoperative nursing after the operation of hepatoma intervention. 30. To investigate the expression and clinical significance of CD 86 in chronic hepatitis and hepatoma.